January 2015<img src="http://feeds.feedburner.com/~r/gim/podcast/current/~4/B_I_poQ_l68" height="1" width="1" alt=""/> <hr> See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for privacy and opt-out information.

January 2015 See acast.com/privacy for privacy and opt-out information.

January 2015 See <a href="https://acast.com/privacy" rel="noopener noreferrer">acast.com/privacy</a> for privacy and opt-out information.

Measuring harm in direct-to-consumer genetic testing

Genetics in Medicine (GIM) is the official journal of the American College of Medical Genetics and Genomics. The journal's mission is to enhance the knowledge, understanding, and practice of medical genetics and genomics through publications in clinical and laboratory genetics and genomics, including ethical, legal, and social issues as well as public health. As genetics and genomics continue to increase in importance and relevance in medical practice, the journal will be an accessible and authoritative resource for the dissemination of medical genetic knowledge to all medical providers through appropriate original research, reviews, commentaries, standards, and guidelines. GIM encourages research that combats racism, includes diverse populations and is written by authors from diverse and underrepresented backgrounds.

Share Measuring harm in direct-to-consumer genetic testing

Sign up to save your podcasts

Measuring harm in direct-to-consumer genetic testing

Measuring harm in direct-to-consumer genetic testing